PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 11/19

PharmD_KS's avatar
PharmD_KS
Nov 18, 2025
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 11/16

There has yet to be a reason to be long this market in any meaningful way. ES traded briefly into its major single prints early in the overnight session which looked remarkably similar to what it did a week or so ago when we also shorted the overnight high:

I added in the Discord something I’ll rarely do, suggesting I would hold short runners until stopped as the risk of a meltdown was significant:

This resolved for more than 110 handles to today’s low.

I was then looking to be out most all the trade at October’s cash hours low, and whichever index (ES or NQ) hit it first:

ES held 2 handles from its October cash hours low of 6591.75, but note the cover response when NQ tagged its cash hours October low of 24384.25 (570 handles from the NQ short entry):

Understanding the difference between a short target and a long setup/entry is key in these situations. In tonight’s plan I’ll discuss what I need to see in order to get long the index.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture